FIELD: chemistry.
SUBSTANCE: invention relates to the formula I compounds or its pharmaceutically acceptable salt or hydrate where Z means N; X1 means O or S, R1 means alkyl containing one to six carbon atoms; R2 designates hydrogen or alkyl containing one to six carbon atoms; and R3 designates hydrogen or alkyl containing one to six carbon atoms substituted with the -ORa group where Ra means alkyl containing one to six carbon atoms; saturated nonaromatic cyclic radical containing 3 to 8 atoms in a cycle where one atom in a cycle is a heteroatom selected from N or O, whereas the rest of the atoms in the cycle are carbon atoms, one or two of these carbon atoms being not necessarily substituted by nitrogen atom with the groups -C(O)(C1-C6alcoxy) or -SO2-C1C6alkyl. Invention also relates to pharmaceutical composition.
EFFECT: compounds possess inhibiting activity.
13 cl, 1 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
BICYCLIC PYRIDINES AND PYRIMIDINES AS KINASE P38 INHIBITORS | 2003 |
|
RU2301233C2 |
HETEROARYLAMINO-SUBSTITUTED BICYCLIC NITROGEN-CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE | 2000 |
|
RU2265606C2 |
DERIVATIVES OF PYRIDOPYRIMIDINES, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2269527C2 |
IMIDAZO-CONDENSED COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2003 |
|
RU2310657C2 |
ALKYLAMINO-SUBSTITUTED BICYCLIC NITROGEN-CONTAINING HETEROCYCLES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2264404C2 |
QUINAZOLINE DERIVATIVES | 2004 |
|
RU2356896C2 |
HYDROXYALKYL-SUBSTITUTED PYRIDO-7-PYRIMIDINE-7ONS | 2004 |
|
RU2348632C2 |
1,4,5-TRISUBSTITUTED IMIDAZOLE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2196139C2 |
DERIVATIVES OF 5-MEMBER HETEROCYCLES AS KINASE p38 INHIBITORS | 2004 |
|
RU2381219C2 |
3-(5)-HETEROARYL-SUBSTITUTED PYRAZOLES AS KINASE P38 INHIBITORS | 1998 |
|
RU2249591C2 |
Authors
Dates
2008-05-20—Published
2003-07-29—Filed